- Theme Lead for Clinical Trials
- University Research Lecturer
My key areas of research expertise are in the design, conduct and transparent reporting of randomized trials and systematic reviews. I have published a number of research studies in these areas including the development of key reporting guidelines such as the CONSORT Statement and PRISMA for Abstracts.
I joined OCTRU in February 2015, where I am involved in leading the design and delivery of clinical trials within the OCTRU portfolio. I am co-chief investigator on a large multicentre NIHR funded (£1.5m) trial of exercise interventions for people with rotator cuff disorders.
I have a particular interest in clinical trial registration, data sharing, transparent reporting of clinical trial protocols, development of core outcome sets, pilot trials and trials of complex interventions. I am a Cochrane editor, associate editor for the journal Research Integrity and Peer Review, sit on the editorial board for the journal Systematic Reviews and am a member of the NIHR Health Technology Assessment Clinical Evaluation and Trials Board and the IDEAL Collaboration. I regularly carry out peer review for high impact medical journals and various funding bodies (e.g. NIHR and Medical Research Council).
Progressive exercise compared with best practice advice, with or without corticosteroid injection, for the treatment of rotator cuff disorders: statistical analysis plan for the Getting it Right: Addressing Shoulder Pain (GRASP) 2 × 2 factorial multicentre randomised controlled trial
Marian IR. et al, (2020), Trials, 21
TIDieR-Placebo: A guide and checklist for reporting placebo and sham controls
Howick J. et al, (2020), PLOS Medicine, 17, e1003294 - e1003294
Items for consideration in a reporting guideline for mediation analyses: a Delphi study
Cashin AG. et al, (2020), BMJ Evidence-Based Medicine
Prediction of RECRUITment In randomized clinical Trials (RECRUIT-IT)-rationale and design for an international collaborative study.
Kasenda B. et al, (2020), Trials, 21
Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Estcourt LJ. et al, (2020), The Cochrane database of systematic reviews, 7